Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Baker Hughes A | BKR | Dec 24, 2024 | 40.79 | +1.59 |
Ball | BALL | Dec 24, 2024 | 56.16 | +0.79 |
Bank Of America | BAC | Dec 24, 2024 | 44.38 | +1.12 |
Bank Of New York Mellon | BK | Dec 24, 2024 | 78.05 | +0.62 |
Baxter International | BAX | Dec 24, 2024 | 29.08 | -0.34 |
Becton, Dickinson And Co | BDX | Dec 24, 2024 | 226.95 | +0.23 |
Berkshire Hathaway B | BRK-B | Dec 24, 2024 | 458.66 | +0.95 |
Best Buy | BBY | Dec 24, 2024 | 86.85 | +1.79 |
Bio-Techne | TECH | Dec 24, 2024 | 73.03 | +0.40 |
Biogen | BIIB | Dec 24, 2024 | 149.02 | -0.24 |
BlackRock | BLK | Dec 24, 2024 | 1 054.83 | +1.46 |
Blackstone | BX | Dec 24, 2024 | 175.69 | +2.03 |
Boeing | BA | Dec 24, 2024 | 179.34 | +0.93 |
Booking | BKNG | Dec 24, 2024 | 5 122.94 | +1.18 |
BorgWarner | BWA | Dec 24, 2024 | 32.18 | +0.56 |
Boston Properties | BXP | Dec 24, 2024 | 76.13 | +0.69 |
Boston Scientific | BSX | Dec 24, 2024 | 91.07 | +1.35 |
Bristol-Myers Squibb | BMY | Dec 24, 2024 | 57.76 | +0.31 |
Broadcom | AVGO | Dec 24, 2024 | 239.68 | +3.15 |
Broadridge Financial Solutions | BR | Dec 24, 2024 | 227.34 | +1.27 |
Brown & Brown | BRO | Dec 24, 2024 | 103.85 | +1.02 |
Brown Forman B | BF-B | Dec 24, 2024 | 39.88 | -0.70 |
Builders Firstsource | BLDR | Dec 24, 2024 | 148.82 | -0.14 |
Bunge | BG | Dec 24, 2024 | 79.10 | +0.06 |
C.H. Robinson Worldwide | CHRW | Dec 24, 2024 | 104.28 | +0.26 |
Cadence Design Systems | CDNS | Dec 24, 2024 | 308.58 | +1.37 |
Caesars Entertainment | CZR | Dec 24, 2024 | 33.33 | +1.34 |
Camden Property Trust | CPT | Dec 24, 2024 | 116.43 | +1.02 |
Campbell Soup | CPB | Dec 24, 2024 | 41.64 | +0.53 |
Capital One Financial | COF | Dec 24, 2024 | 182.12 | +1.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.